In Phase 3 TRIUMPH-1 data, diarrhea was reported in 25.2% to 34.1% of participants taking retatrutide, constipation in 23.8% to 26.1%, and vomiting in 10.6% to 25.3%, compared with lower rates among participants receiving placebo
Joenja (FDA approved March 2023) Pharming received approval for Joenja (leniolisib), the first treatment for patients with activated PI3K Delta syndrome, an ultra-rare autoimmune disorder characterized by recurrent respiratory infections and immune dysregulation with only 200 identified patients in the U.S
It was different for us because Miles is really an active kid
Toll-like receptor 4 (TLR4) binds to various types of ligands such as lipopolysaccharides (LPS), low-density lipoproteins, and heat-shock proteins (77, 78)
Animal studies suggest sublingual bioavailability may be significantly higher than oral tablet bioavailability
These actions may seem like a way to save money, but they can lead to health problems later on